Related Experiment Video
Updated: Apr 14, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Diagnosis and treatment of cervical artery dissection
Stefan T Engelter1, Christopher Traenka2, Alexander Von Hessling3
1Department of Neurology and Stroke Center, University Hospital Basel, Petersgraben 4, Basel CH - 4031, Switzerland; Neurorehabilitation Unit, Felix Platter Hospital, University Center for Medicine of Aging and Rehabilitation, Burgfelderstrasse 101, Basel CH - 4012, Switzerland.
Insights
Cervical artery dissection (CAD) stroke in young adults may benefit from intravenous thrombolysis despite mural hematoma. Endovascular treatment and antithrombotic choices are crucial for optimal recovery in these patients.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Cardiology
Background:
- Cervical artery dissection (CAD) is a leading cause of stroke in young individuals.
- Mural hematoma is a common finding in CAD patients, raising concerns about treatment options.
Purpose of the Study:
- To evaluate the safety and efficacy of intravenous thrombolysis in CAD patients with mural hematoma.
- To discuss alternative treatments like endovascular therapy for CAD-related stroke.
- To analyze antithrombotic strategies, including anticoagulants versus antiplatelets, for CAD management.
Main Methods:
- Review of 4 meta-analyses on observational data concerning antithrombotic agents.
- Analysis of current data from 3 randomized controlled trials.
- Discussion of arguments for and against anticoagulants versus antiplatelets.
- Consideration of the roles of stenting and surgical interventions.
Main Results:
- Mural hematoma in CAD should not preclude the use of intravenous thrombolysis.
- Intravenous thrombolysis in CAD patients may be associated with suboptimal recovery compared to other stroke types.
- Acute endovascular treatment presents a viable alternative for CAD-related stroke.
- Evidence from meta-analyses and ongoing trials informs the debate on anticoagulant vs. antiplatelet therapy.
Conclusions:
- Intravenous thrombolysis can be considered in CAD patients with mural hematoma.
- Endovascular treatment is a key alternative for CAD-related strokes.
- The optimal antithrombotic strategy requires careful consideration of current evidence and ongoing research.
Abstract:
Cervical artery dissection (CAD) is a major cause of stroke in the young. A mural hematoma is detected in most CAD patients. The intramural blood accumulation should not be considered a reason to withhold intravenous thrombolysis in patients with CAD-related stroke. Because intravenous-thrombolyzed CAD patients might not recover as well as other stroke patients, acute endovascular treatment is an alternative. Regarding the choice of antithrombotic agents, this article discusses the findings of 4 meta-analyses across observational data, the current status of 3 randomized controlled trials, and arguments and counterarguments favoring anticoagulants over antiplatelets. Furthermore, the role of stenting and surgery is addressed.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease V: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aneurysm IV: Nursing Management

